Insmed (INSM) Inventory (2018 - 2026)
Insmed (INSM) recorded quarterly Inventory of $132.9 million in Q1 2026, up 0.64% quarter-over-quarter from $132.1 million in Q4 2025, and up 31.97% on a YoY basis from $100.7 million in Q1 2025.
Insmed (INSM) Inventory (2018 - 2026) Analysis & Trends
Insmed's Inventory history runs 9 years deep, the most recent figure standing at $132.9 million for Q1 2026.
- In Q1 2026, Inventory rose 31.97% year-over-year to $132.9 million; the TTM figure through Mar 2026 stood at $132.9 million (up 31.97% YoY), while the FY2025 annual figure was $132.1 million, up 33.97% from the prior year.
- Inventory was $132.9 million for Q1 2026 at Insmed, up from $132.1 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $132.9 million in Q1 2026 to a low of $64.1 million in Q1 2022.
- Historically, Inventory has averaged $90.7 million across 5 years, with a median of $83.2 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Inventory dropped 1.74% in 2022, then surged 33.97% in 2025.
- A 5-year view of Inventory shows it stood at $69.9 million in 2022, then climbed by 19.06% to $83.2 million in 2023, then grew by 18.41% to $98.6 million in 2024, then soared by 33.97% to $132.1 million in 2025, then increased by 0.64% to $132.9 million in 2026.
- The last three Inventory figures came in at $132.9 million (Q1 2026), $132.1 million (Q4 2025), and $121.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 132.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 132.91 Mn |
| Dec 31, 2025 | 132.07 Mn |
| Sep 30, 2025 | 120.97 Mn |
| Jun 30, 2025 | 107.61 Mn |
| Mar 31, 2025 | 100.71 Mn |
| Dec 31, 2024 | 98.58 Mn |
| Sep 30, 2024 | 98.47 Mn |
| Jun 30, 2024 | 90.06 Mn |
| Mar 31, 2024 | 82.96 Mn |
| Dec 31, 2023 | 83.25 Mn |
| Sep 30, 2023 | 77.92 Mn |
| Jun 30, 2023 | 77.35 Mn |
| Mar 31, 2023 | 71.32 Mn |
| Dec 31, 2022 | 69.92 Mn |
| Sep 30, 2022 | 66.28 Mn |
| Jun 30, 2022 | 67.02 Mn |
| Mar 31, 2022 | 64.15 Mn |
| Dec 31, 2021 | 67.01 Mn |
| Sep 30, 2021 | 67.45 Mn |
| Jun 30, 2021 | 60.39 Mn |